publication . Article . 2007

Achalasia. Controversy of treatment

Restrepo P, Antonio J; Rey T, Mario H; Garzón O, Martín A; Farfán Q, Yesid A; Molano V, Juan C; Marulanda, Juan C; Lizarazo, Jorge I;
Open Access
  • Published: 01 Jan 2007
  • Publisher: Asociacion Colombiana de Gastroenterologia
  • Country: Bolivia
Abstract
La acalasia es un desorden motor del esófago caracterizado por pérdida de la peristalsis esofágica con falta en la relajación o relajación incompleta del esfínter esofágico inferior (EEI) (1). La causa exacta de este trastorno es desconocida. Los síntomas más comunes son disfagia, regurgitación, pérdida de peso y dolor torácico (2). La manometría esofágica es el principal método diagnóstico, mostrando aperistalsis del cuerpo esofágico con aumento de la presión, falta de relajación o relajación incompleta del EEI (3, 4). La meta del tratamiento es reducir la presión del EEI para que la gravedad pueda facilitar el vaciamiento esofágico, ya que no existe ningún tra...
Subjects
free text keywords: Acalasia, dilatación neumática, toxina botulínica, miotomía laparoscópica de Heller, Achalasia, Pneumatic Dilatation, Botulinum Toxin, Laparoscopic Heller Myotomy
Related Organizations
36 references, page 1 of 3

1. O'Connor J. Barry, Singer Mendel E, et al. The CostEffectiveness of Treatment Starategies for Achalasia. Digestive Diseases and Sciences 2002; 47(7).

2. Park Woosuk, Vaezi Michael F. Etiology and Pathogenesis of Achalasia:The Current Understanding. Am J Gastroenterol 2005; 100: 1404-1414. [OpenAIRE]

3. Woltman Todd A, Pelligrini Carlos A. Achalasia. Surg Clin N Am 2005; 85: 483-493.

4. Saud B, Szyjkowski R. A diagnostic approach to Dysphagia. Clin Fam Pract 2004; 6(3): 525.

5. Zhao Xiaotuan, Pasricha Pankaj Jay. Botulinum toxin for spastic GI disorders: A systematic review. Gastrointestinal Endoscopy 2003; 57 (2).

6. Pehlivanov N, Pasricha Pankaj Jay. Achalasia: botox, dilatation or laparoscopic surgery in 2006. Neurogastroenterol Motil 2006; 18: 799-804.

7. Lake JM, Wong RKH. Review article: the management of achalasia - a comparison of different treatment modalities. Aliment Pharmacol Ther 2006; 24: 909-918.

8. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994; 121: 590-1. [OpenAIRE]

9. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774-8. [OpenAIRE]

10. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5. [OpenAIRE]

11. Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91: 1724-30.

12. Gordon JM, Eaker EY. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol 1997; 92: 1812-7.

13. Cuilliere C, Ducrotte P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41: 87-92. [OpenAIRE]

14. Wehrmann T, Kokabpick H, Jacobi V, Seifert H, Lembcke B, Caspary WF. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy 1999; 31: 352-8.

15. Kolbasnik J, Waterfall WE, Fachnie B, Chen Y, Tougas G. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol 1999; 94: 3434-9. [OpenAIRE]

36 references, page 1 of 3
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2007

Achalasia. Controversy of treatment

Restrepo P, Antonio J; Rey T, Mario H; Garzón O, Martín A; Farfán Q, Yesid A; Molano V, Juan C; Marulanda, Juan C; Lizarazo, Jorge I;